MedKoo Cat#: 406991 | Name: IDH889

Description:

WARNING: This product is for research use only, not for human or veterinary use.

IDH889 is a potent and selective inhibitors of IDH1. IDH899 shows IDH (R132H) IC50 = 20 nM; Cell 2-HG IC50 = 14 nM. IDH889 demonstrates significantly improved plasma exposure in mice vs IDH662 (AUC 3.6 μM·h, Cmax 1.7 μM at 10 mg/kg; AUC 55.5 μM·h, Cmax 14.2 μM at 100 mg/kg). IDH889 also has excellent permeability and no efflux in the Caco-2 and human MDR1-MDCK cell lines, supporting the hypothesis that potent inhibition of mutant IDH1 function by binding at the allosteric binding site is compatible with brain penetration.

Chemical Structure

IDH889
IDH889
CAS#1429179-07-6

Theoretical Analysis

MedKoo Cat#: 406991

Name: IDH889

CAS#: 1429179-07-6

Chemical Formula: C23H25FN6O2

Exact Mass: 436.2023

Molecular Weight: 436.49

Elemental Analysis: C, 63.29; H, 5.77; F, 4.35; N, 19.25; O, 7.33

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
IDH889; IDH-889; IDH 889.
IUPAC/Chemical Name
(S)-3-(2-(((S)-1-(5-(4-fluoro-3-methylphenyl)pyrimidin-2-yl)ethyl)amino)pyrimidin-4-yl)-4-isopropyloxazolidin-2-one
InChi Key
JDCYIMQAIKEACU-HNAYVOBHSA-N
InChi Code
InChI=1S/C23H25FN6O2/c1-13(2)19-12-32-23(31)30(19)20-7-8-25-22(29-20)28-15(4)21-26-10-17(11-27-21)16-5-6-18(24)14(3)9-16/h5-11,13,15,19H,12H2,1-4H3,(H,25,28,29)/t15-,19+/m0/s1
SMILES Code
CC1=C(F)C=CC(C2=CN=C([C@@H](NC3=NC(N4[C@@H](C(C)C)COC4=O)=CC=N3)C)N=C2)=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Hotspot heterozygous mutations in human cytoplasmic isocitrate dehydrogenase 1 (IDH1) at Arg132 (R132*) have been identified in multiple cancer types, including acute myeloid leukemia (AML), glioma, chondrosarcoma, and cholangiocarcinoma.

Preparing Stock Solutions

The following data is based on the product molecular weight 436.49 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1 Julian R. LevellThomas CaferroGregg ChenailIna DixJulia DooleyBrant FirestonePascal D. FortinJohn GiraldesTy GouldJoseph D. GrowneyMichael D. JonesRaviraj KulathilaFallon LinGang LiuArne MuellerSimon van der PlasKelly SlocumTroy SmithRemi TerranovaB. Barry TouréViraj TyagiTrixie WagnerXiaoling XieMing XuFan S. YangLiping X. ZhouRaymond PagliariniYoung Shin Cho Publication Date (Web): December 16, 2016 (Letter) DOI: 10.1021/acsmedchemlett.6b00334